HALOZYME THERAPEUTICS, INC.
HALO
42 insider filings · Latest: Oct 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 11:56 PM | Helen TorleyDirector, PRESIDENT AND CEO | Sale | 20,000 | $69.69 | $1.4M | 767,780(D) | View → |
| Feb 5, 2026 | Feb 6 12:38 AM | Helen TorleyDirector, PRESIDENT AND CEO | Sale | 10,000 | $78.64 | $786.4K | 708,719(D) | View → |
| Feb 4, 2026 | Feb 6 12:38 AM | Helen TorleyDirector, PRESIDENT AND CEO | Sale | 20,000 | $77.24 | $1.5M | 708,719(D) | View → |
| Feb 3, 2026 | Feb 6 12:38 AM | Helen TorleyDirector, PRESIDENT AND CEO | Sale | 20,000 | $76.12 | $1.5M | 708,719(D) | View → |
| Feb 3, 2026 | Feb 3 9:17 PM | Helen Torley | Proposed Sale | 150,000 | $74.45 | $11.2M | — | View → |
| Jan 5, 2026 | Jan 5 9:39 PM | BERNADETTE CONNAUGHTON | Proposed Sale | 2,000 | $70.31 | $140.6K | — | View → |
| Oct 1, 2025 | Oct 1 8:26 PM | Helen Torley | Proposed Sale | 136,569 | $73.34 | $10.0M | — | View → |
| Sep 10, 2025 | Sep 10 8:37 PM | NICOLE LABROSSE | Proposed Sale | 22,227 | $76.07 | $1.7M | — | View → |
| Sep 2, 2025 | Sep 2 8:38 PM | BERNADETTE CONNAUGHTON | Proposed Sale | 8,829 | $73.15 | $645.8K | — | View → |
| Jun 20, 2025 | Jun 20 8:25 PM | Helen Torley | Proposed Sale | 240,000 | $53.15 | $12.8M | — | View → |
| Feb 25, 2025 | Feb 25 9:32 PM | MICHAEL LABARRE | Proposed Sale | 21,697 | $58.50 | $1.3M | — | View → |
| Feb 3, 2025 | Feb 3 9:21 PM | JEFFREY HENDERSON | Proposed Sale | 15,000 | $56.64 | $849.6K | — | View → |
| Jan 6, 2025 | Jan 6 9:26 PM | JEFFREY HENDERSON | Proposed Sale | 10,000 | $47.74 | $477.4K | — | View → |
| Oct 16, 2024 | Oct 16 8:14 PM | MICHAEL LABARRE | Proposed Sale | 10,000 | $53.26 | $532.6K | — | View → |
| Oct 15, 2024 | Oct 15 8:34 PM | MICHAEL LABARRE | Proposed Sale | 10,000 | $53.75 | $537.5K | — | View → |
| Oct 9, 2024 | Oct 9 8:09 PM | HELEN TORLEY | Proposed Sale | 10,000 | $52.58 | $525.8K | — | View → |
| Oct 8, 2024 | Oct 8 8:08 PM | HELEN TORLEY | Proposed Sale | 10,000 | $54.00 | $540.0K | — | View → |
| Sep 26, 2024 | Sep 26 8:05 PM | HELEN TORLEY | Proposed Sale | 10,000 | $56.10 | $561.0K | — | View → |
| Sep 25, 2024 | Sep 25 8:00 PM | HELEN TORLEY | Proposed Sale | 10,000 | $56.34 | $563.4K | — | View → |
| Sep 24, 2024 | Sep 24 8:05 PM | HELEN TORLEY | Proposed Sale | 10,000 | $58.21 | $582.1K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Oct 8 11:56 PM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 21,552(D) | View → |
| Oct 7, 2026 | Oct 8 11:56 PM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 41,552(D) | View → |
| Oct 6, 2026 | Oct 8 11:56 PM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 61,552(D) | View → |
| Oct 1, 2026 | Oct 2 8:43 PM | James M DalyDirector | Grant/Award | 1,775 | $106.94 | 1,775(D) | View → |
| Sep 11, 2026 | Sep 12 12:35 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 81,552(D) | View → |
| Sep 10, 2026 | Sep 12 12:35 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 101,552(D) | View → |
| Sep 9, 2026 | Sep 12 12:35 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 121,552(D) | View → |
| Sep 1, 2026 | Sep 2 8:59 PM | Dannielle AppelhansDirector | Grant/Award | 1,778 | $107.72 | 1,778(D) | View → |
| Aug 19, 2026 | Aug 20 12:01 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 141,552(D) | View → |
| Aug 18, 2026 | Aug 20 12:01 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 161,552(D) | View → |
| Aug 17, 2026 | Aug 20 12:01 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $18.41 | 181,552(D) | View → |
| Jul 8, 2026 | Jul 9 9:19 PM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 1,923 | $12.07 | 0(D) | View → |
| Jul 1, 2026 | Jul 2 8:45 PM | David A RamsayEVP, PRESIDENT, DRUG DELIVERY | Grant/Award | 56,055 | $77.01 | 39,823(D) | View → |
| Jun 30, 2026 | Jul 2 8:45 PM | David A RamsayEVP, PRESIDENT, DRUG DELIVERY | Option Exercise | 10,000 | $0.00 | 0(D) | View → |
| Jul 1, 2026 | Jul 2 8:44 PM | Darren SnellgroveSVP, Chief Financial Officer | Grant/Award | 168,986 | $77.01 | 127,432(D) | View → |
| Jun 29, 2026 | Jun 30 9:25 PM | Mahesh KrishnanDirector | Option Exercise | 7,304 | $38.46 | 1,500(D) | View → |
| Jun 12, 2026 | Jun 15 8:09 PM | Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Option Exercise | 5,034 | $0.00 | 10,068(D) | View → |
| Jun 3, 2026 | Jun 4 12:06 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 10,000 | $12.07 | 1,923(D) | View → |
| Jun 2, 2026 | Jun 4 12:06 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $12.07 | 11,923(D) | View → |
| Jun 1, 2026 | Jun 4 12:06 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $12.07 | 31,923(D) | View → |
Page 1 of 3
Next →